<DOC>
	<DOCNO>NCT00960193</DOCNO>
	<brief_summary>Seville orange juice inhibitor intestinal cytochrome P450 ( CYP ) 3A4 enzyme , one enzymes responsible metabolism colchicine . This study evaluate effect multiple daily consumption Seville orange juice pharmacokinetic profile single 0.6 mg dose colchicine . A secondary objective evaluate safety tolerability regimen healthy volunteer . All study subject monitor adverse event throughout study period .</brief_summary>
	<brief_title>Drug-Food Interaction Study Seville Orange Juice Colchicine</brief_title>
	<detailed_description>Seville orange juice inhibitor intestinal cytochrome P450 ( CYP ) 3A4 enzyme , one enzymes responsible metabolism colchicine . This study evaluate effect multiple daily consumption Seville orange juice pharmacokinetic profile single 0.6 mg dose colchicine . Twenty-four healthy , non-smoking , non-obese , non-pregnant adult volunteer age 18 45 give one dose colchicine ( 1 x 0.6 mg tablet ) Day 1 , overnight fast . Fasting continue 4 hour dose . Blood sample draw participant dose 24 hour post-dose adequately define baseline pharmacokinetics colchicine . After 14 day washout period , start morning Day 15 continue Day 17 , subject return clinic consumption administer 240 ml dose Seville orange juice morning evening . At 8am Day 18 overnight fast , subject receive co-administered single oral dose colchicine ( 1 x 0.6 mg ) Seville orange juice ( 1 x 240 ml ) . Fasting continue 4 hour dose . Blood sample draw participant dose 24 hour post-dose adequately define pharmacokinetics colchicine presence Seville orange juice . Subjects consume final administer 240 ml dose Seville orange juice even Day 18 . A goal study evaluate safety tolerability regimen healthy volunteer . Subjects monitor throughout participation study adverse reaction study drug and/or procedure . Seated blood pressure pulse measure prior dose approximately 1 , 2 , 3 hour follow drug administration Days 1 18 coincide peak plasma concentration colchicine . All adverse event whether elicited query , spontaneously report , observe clinic staff evaluate investigator report subject 's case report form .</detailed_description>
	<mesh_term>Colchicine</mesh_term>
	<criteria>Healthy adult 1845 year age Nonsmoking nonpregnant ( postmenopausal , surgically sterile use effective contraceptive measure ) Body mass index ( BMI ) great equal 18 less equal 32 , inclusive Hemoglobin great equal 11.5g/dL Recent participation ( within 28 day ) research study Recent significant blood donation plasma donation Pregnant lactate Test positive screening human immunodeficiency virus ( HIV ) , hepatitis B surface antigen ( HbsAg ) , hepatitis C virus ( HCV ) Recent ( 2year ) history evidence alcoholism drug abuse History presence significant cardiovascular , pulmonary , hepatic , gallbladder biliary tract , renal , hematologic , gastrointestinal , endocrine , immunologic , dermatologic , neurologic , psychiatric disease Subjects use drug substance know inhibit induce cytochrome ( CYP ) P450 enzymes and/or Pglycoprotein ( Pgp ) within 28 day prior first dose throughout study Drug allergy colchicine Intolerance food allergy Seville orange juice</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>blood level time</keyword>
	<keyword>colchicine</keyword>
	<keyword>seville orange juice</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>